Quick Answer
Protara Therapeutics, Inc. reported Shares Outstanding of 53.59 million shares for fiscal year 2025.
Protara Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 53.59M | +52.9% |
| 2024 | 35.04M | +208.4% |
| 2023 | 11.36M | +0.9% |
| 2022 | 11.27M | +0.3% |
| 2021 | 11.24M | +0.2% |
| 2020 | 11.21M | +326.7% |
| 2019 | 2.63M | +446.2% |
| 2018 | 481,091 | -97.3% |
| 2017 | 17.67M | +6.5% |
| 2016 | 16.60M | +0.6% |
| 2015 | 16.50M | +0.3% |
| 2014 | 16.45M | +6756.2% |
| 2013 | 239,905 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 38.59M | +87.0% | +0.0% |
| June 30, 2025 | 38.58M | +239.5% | +0.0% |
| March 31, 2025 | 38.58M | +237.4% | +10.1% |
| December 31, 2024 | 35.04M | +208.4% | +69.9% |
| September 30, 2024 | 20.63M | +81.5% | +81.5% |
| June 30, 2024 | 11.36M | +0.5% | -0.6% |
| March 31, 2024 | 11.43M | +1.1% | +0.6% |
| December 31, 2023 | 11.36M | +0.9% | +0.0% |
- Protara Therapeutics, Inc. showed an increase of +52.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Protara Therapeutics, Inc.’s shares outstanding has grown by 22236.9% (from 239.9 thousand shares to 53.59 million shares).
- The most recent figure is from Protara Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: